Selvita - your integrated drug discovery partner of choice

The largest drug
discovery company
in the CEE region

Your integrated drug
discovery partner of choice

Developing breakthrough
therapies in oncology

Delivering comprehensive
research solutions to biotech
and pharma

Krakow, Poland – 30 May 2018 – Selvita is participating and presenting at the 4th Annual Immuno-Oncology BD&L and Investment Forum,...

Krakow, Poland – 25 May 2018 – Selvita, one of the largest drug discovery companies in Europe, has recently published...

Krakow, Poland – 08 May 2018 – Selvita and Sandoz researchers have recently jointly published an article: “A short synthesis...

Krakow, Poland - 26 April 2018 - Institute of Hematology and Transfusion Medicine, the leading Polish hematology and blood transfusion...

Kraków, Poland – 23 April 2018 – Selvita will participate in the 2018 edition of BioTrinity conference, taking place in...

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.

In its internal research and development efforts, Selvita focuses on different dimensions of oncology.

The company’s most advanced R&D program is SEL24, a dual PIM/FLT3 kinase inhibitor currently in Phase I/II clinical study, in acute myeloid leukemia.

53,80 PLN More

We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.